Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Adenosine A3 antagonists from Merck & Co.

June 28, 1996

Eisai's ER-27319: Potential in treating allergic diseases

June 28, 1996

GCC-AP0341: Green Cross' eosinophilia inhibitor

June 28, 1996

5-lipoxygenase and cyclooxygenase inhibitors from Abbott

June 28, 1996

Abbott discloses 5-lipoxygenase inhibitors

June 28, 1996

Leukotriene biosynthesis inhibitors from Merck Frosst

June 28, 1996

Proctor & Gamble acquires Dura products

June 28, 1996

Thymosin beta4 as cystic fibrosis treatment

June 21, 1996

Astra's Pulmicort approaches FDA approval

June 21, 1996

B2 antagonists from Servier

June 21, 1996